【24h】

Transplant Renal Vein Thrombosis

机译:移植肾静脉血栓形成

获取原文
       

摘要

Transplant renal vein thrombosis usually occurs early after surgery with a reported prevalence of 0.1% to 4.2%. It is a devastating event that ultimately leads to graft loss in almost all cases. There are many pre-disposing factors related to donor, recipient, surgery, and immunosuppression, with mechanical factors being considered the most common causes of transplant renal vein thrombosis. The clinical mani-festations of acute renal vein thrombosis are nonspecific and are not dissimilar to the features of urine leak, urinary obstruction, or severe acute rejection. The diagnosis of transplant renal vein thrombosis depends on a high index of clinical sus-picion and duplex ultrasonographic scans. Although venography remains the criterion standard, this procedure is invasive and nephrotoxic, due to use of ionizing contrast agents and also due to exposure to ionizing radiation. There are 2 therapies that have been described in the literature for salvaging a renal allograft with transplant renal vein thrombosis: thrombolytic therapy and surgical thrombectomy. The usual end result is renal allograft nephrectomy because the diagnosis is almost always too late.
机译:移植肾静脉血栓形成通常发生在手术后早期,据报道患病率为0.1%至4.2%。这是一个毁灭性事件,最终导致几乎所有情况下的移植物丢失。有许多与供体,受体,手术和免疫抑制有关的诱发因素,其中机械因素被认为是移植肾静脉血栓形成的最常见原因。急性肾静脉血栓形成的临床表现是非特异性的,并且与尿液渗漏,尿路阻塞或严重急性排斥反应的特征无异。移植肾静脉血栓形成的诊断取决于临床怀疑和双重超声检查的高指数。尽管静脉造影术仍然是标准的标准,但是由于使用了电离造影剂并且还由于暴露于电离辐射,因此该过程具有侵入性和肾毒性。在文献中已经描述了两种用于挽救移植肾静脉血栓的同种异体肾的疗法:溶栓疗法和外科血栓切除术。通常的最终结果是进行同种异体肾切除术,因为诊断几乎总是为时已晚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号